Acetaminophen tablets recalled for incorrect imprinting
Akron Pharma is recalling Acetaminophen Regular Strength 325 mg tablets due to incorrect imprinting on the tablets. The recall involves approximately 6,429 bottles distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: FDA Class III recall for a labeling and identification issue with no reported illnesses or injuries, making this a low-risk precautionary recall.
Plain-English summary
Akron Pharma, Inc. is recalling Acetaminophen Regular Strength tablets, 325 mg, in bottles of 100 tablets. The tablets are imprinted with incorrect identification. The affected product is lot number KDT0124001 with an expiration date of August 31, 2026, NDC number 71399-8024-01.
Approximately 6,429 bottles were distributed nationwide throughout the United States. This is a Class III recall issued by the U.S. Food and Drug Administration.
The recalled product
- Product
- Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .
- Manufacturer
- Akron Pharma, Inc.
- Category
- Drug
- Hazard
- Affected units
- 6,429
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: KDT0124001
- Exp 08/31/2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by Akron Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Akron Pharma, Inc.
See all →- LowDiphenhydramine HCl 50 mg Capsules Recalled Due to Incorrect ID Imprinting
FDA (Drugs) · 2025-01-22
- ModerateAcetaminophen 325 mg tablets recalled for incorrect imprinting
FDA (Drugs) · 2025-01-22
- LowDiphenhydramine HCl Capsules Recalled Due to Wrong ID Imprinting
FDA (Drugs) · 2025-01-22
- ModerateAcetaminophen Extra Strength tablets recalled for incorrect product imprint identification
FDA (Drugs) · 2025-01-22
- ModerateDiphenhydramine HCl Capsules Recalled Due to Wrong Imprinting
FDA (Drugs) · 2025-01-22
Same hazard · mis labeling
See all →- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White Herbal Supplement Recalled for Undeclared Walnut Allergen
FDA (Food) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- HighHalyard DAVINCI TRUCUSTOM Foley Catheter Kits Recalled for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02